Product Information
VANCOMYCIN HCL 125 MG CAPSULE is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $1.4207 per EA under NDC 68180016613. Its NADAC has been published 558 times since Apr 29, 2015.
Strength
125 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180016613
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
12/17/2025
Active Ingredients
VANCOMYCIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090439On Market Since
3/27/2015
Pharmacological Classes
Price Statistics
The NADAC for VANCOMYCIN HCL 125 MG CAPSULE has been published 558 times since Apr 29, 2015, and over the history we have for it it has declined 87.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4207 per EA |
|---|---|
| All-time high | $11.6719 (May 13, 2015) |
| All-time low | $0.9333 (Nov 20, 2024) |
| 52-week high | $1.4268 |
| 52-week low | $1.2774 |
| Median price | $2.6947 |
| Average price | $3.7527 |
| Largest weekly change | +35.0% (May 18, 2022) |
| Weeks tracked | 558 |
| Tracking since | Apr 29, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the VANCOMYCIN HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of VANCOMYCIN HCL 125 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for VANCOMYCIN HCL 125 MG CAPSULE, manufactured by Lupin Pharmaceuticals Inc., is $1.4207 per EA (NDC 68180016613), effective Dec 31, 2025.
How has the price of VANCOMYCIN HCL 125 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for VANCOMYCIN HCL 125 MG CAPSULE has declined 87.8%. It has been tracked across 558 weekly CMS publications since Apr 29, 2015.
What are the highest and lowest recorded NADAC prices for VANCOMYCIN HCL 125 MG CAPSULE?
Since Apr 29, 2015, the NADAC for VANCOMYCIN HCL 125 MG CAPSULE has ranged from a low of $0.9333 (Nov 20, 2024) to a high of $11.6719 (May 13, 2015), with a median of $2.6947 per EA.
Are there cheaper alternatives to VANCOMYCIN HCL 125 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of VANCOMYCIN HCL 125 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures VANCOMYCIN HCL 125 MG CAPSULE?
VANCOMYCIN HCL 125 MG CAPSULE (NDC 68180016613) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification